SYLVANT subst sèche 100 mg flac
7680651830015
CH-65183
L04AC11
07.16.1.
1 / 3
google
Details
- Product number
- 6518301
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: siltuximabum 110 mg, saccharum, histidini hydrochloridum monohydricum aut histidinum, polysorbatum 80, pro vitro.
Articles (1)
Sylvant 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
110.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
Authorization holder
Medius AG
4132 Muttenz
Authorization information
- Swissmedic authorization number
- 65183
- Drug name
- Sylvant, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPA
- ATC Code
- L04AC11
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 17/12/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SYLVANT subst sèche 100 mg flac
- Description (DE)
- SYLVANT Trockensub 100 mg Durchstf
- Market launch
- 17/12/2014
- Narcotic (BTM)
- No